Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc., and Cooley advised the underwriters.Dyne Therapeutics, Inc. (Nasdaq:DYN) (“Dyne”) announced the closing of an underwritten public offering of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now